R57.0
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Cardiogenic shock with a clinical indication for VA-ECMO therapy Age > 18 years
Exclusion criteria
Exclusion criteria: Insufficient hemodynamic stability despite established VA-ECMO therapy to safely perform study procedures Lack of the possibility to obtain safe venous vascular access Patients with an implanted pacemaker or transvenous implantable cardioverter-defibrillator (ICD) Patients younger than 18 years of age Presence of pregnancy and other particularly vulnerable populations Conditions that make it impossible to obtain informed consent from a legal representative for study participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in right ventricular myocardial oxygen consumption when comparing the highest versus lowest rotational speed range of VA-ECMO. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in external ventricular work Change in internal ventricular work Change in pulmonary artery (PA) pressures Change in pulmonary capillary wedge pressure (PCWP) Change in PCWP in relation to external ventricular work RV volume at an RV end-diastolic pressure (RV-EDP) of 10 mmHg Change in RV-EDP RV end-diastolic pressure–volume relationship (RV-EDPVR) Change in RV end-diastolic volume (RV-EDV) RV end-systolic pressure–volume relationship (RV-ESPVR) RV volume at an RV end-systolic pressure (RV-ESP) of 40 mmHg Change in right ventricular afterload (Ea) Change in stroke volume Change in dP/dtmin Change in dP/dtmax Change in heart rate Mortality at 2-year follow-up | — |
Countries
Germany
Contacts
Johannes-Gutenberg-Universität Mainz – Universitätsmedizin; Zentrum für Kardiologie